These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 22525377

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Effects of selective endothelin (ET)-A receptor antagonist versus dual ET-A/B receptor antagonist on hearts of streptozotocin-treated diabetic rats.
    Miyauchi Y, Jesmin S, Sakai S, Kamiyama J, Shimojo N, Rahman A, Islam M, Zaedi S, Maeda S, Maruyama H, Mizutani T, Homma S, Aonuma K, Miyauchi T.
    Life Sci; 2014 Aug 28; 111(1-2):6-11. PubMed ID: 24953608
    [Abstract] [Full Text] [Related]

  • 4. Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist.
    Iglarz M, Binkert C, Morrison K, Fischli W, Gatfield J, Treiber A, Weller T, Bolli MH, Boss C, Buchmann S, Capeleto B, Hess P, Qiu C, Clozel M.
    J Pharmacol Exp Ther; 2008 Dec 28; 327(3):736-45. PubMed ID: 18780830
    [Abstract] [Full Text] [Related]

  • 5. Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.
    Zoja C, Cattaneo S, Fiordaliso F, Lionetti V, Zambelli V, Salio M, Corna D, Pagani C, Rottoli D, Bisighini C, Remuzzi G, Benigni A.
    Am J Physiol Renal Physiol; 2011 Nov 28; 301(5):F1114-23. PubMed ID: 21816757
    [Abstract] [Full Text] [Related]

  • 6. Differential activation of NF-kappa B and AP-1 in increased fibronectin synthesis in target organs of diabetic complications.
    Chen S, Khan ZA, Cukiernik M, Chakrabarti S.
    Am J Physiol Endocrinol Metab; 2003 Jun 28; 284(6):E1089-97. PubMed ID: 12582013
    [Abstract] [Full Text] [Related]

  • 7. SIRT1 reduction causes renal and retinal injury in diabetes through endothelin 1 and transforming growth factor β1.
    Mortuza R, Feng B, Chakrabarti S.
    J Cell Mol Med; 2015 Aug 28; 19(8):1857-67. PubMed ID: 25753689
    [Abstract] [Full Text] [Related]

  • 8. Endothelins: regulators of extracellular matrix protein production in diabetes.
    Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, Chan BM, Uniyal S, Chakrabarti S.
    Exp Biol Med (Maywood); 2006 Jun 28; 231(6):1022-9. PubMed ID: 16741042
    [Abstract] [Full Text] [Related]

  • 9. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
    Masuzawa K, Jesmin S, Maeda S, Zaedi S, Shimojo N, Miyauchi T, Goto K.
    Exp Biol Med (Maywood); 2006 Jun 28; 231(6):1090-4. PubMed ID: 16741055
    [Abstract] [Full Text] [Related]

  • 10. Diabetes-induced myocardial structural changes: role of endothelin-1 and its receptors.
    Chen S, Evans T, Mukherjee K, Karmazyn M, Chakrabarti S.
    J Mol Cell Cardiol; 2000 Sep 28; 32(9):1621-9. PubMed ID: 10966825
    [Abstract] [Full Text] [Related]

  • 11. Inhibiting albumin glycation attenuates dysregulation of VEGFR-1 and collagen IV subchain production and the development of renal insufficiency.
    Cohen MP, Lautenslager GT, Hud E, Shea E, Wang A, Chen S, Shearman CW.
    Am J Physiol Renal Physiol; 2007 Feb 28; 292(2):F789-95. PubMed ID: 17018845
    [Abstract] [Full Text] [Related]

  • 12. Diabetes-induced vascular dysfunction in the retina: role of endothelins.
    Deng D, Evans T, Mukherjee K, Downey D, Chakrabarti S.
    Diabetologia; 1999 Oct 28; 42(10):1228-34. PubMed ID: 10525664
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of selective endothelin type a receptor antagonist on the gene expression of vascular endothelial growth factor and its receptors in streptozotocin-induced diabetic heart.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Shimojo N, Masuzawa K, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 28; 231(6):902-6. PubMed ID: 16741021
    [Abstract] [Full Text] [Related]

  • 14. Endothelin-mediated remodeling in aortas of diabetic rats.
    Fukuda G, Khan ZA, Barbin YP, Farhangkhoee H, Tilton RG, Chakrabarti S.
    Diabetes Metab Res Rev; 2005 Jun 28; 21(4):367-75. PubMed ID: 15580650
    [Abstract] [Full Text] [Related]

  • 15. Renoprotective effect of COMP-angiopoietin-1 in db/db mice with type 2 diabetes.
    Lee S, Kim W, Moon SO, Sung MJ, Kim DH, Kang KP, Jang KY, Lee SY, Park BH, Koh GY, Park SK.
    Nephrol Dial Transplant; 2007 Feb 28; 22(2):396-408. PubMed ID: 17085463
    [Abstract] [Full Text] [Related]

  • 16. Effects of dual endothelin receptor antagonist on antiapoptotic marker Bcl-2 expression in streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Yamaguchi N, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 28; 231(6):1034-9. PubMed ID: 16741044
    [Abstract] [Full Text] [Related]

  • 17. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H, Oh EY, Seo JY, Yu MR, Kim YO, Ha H, Lee HB.
    Am J Physiol Renal Physiol; 2009 Sep 28; 297(3):F729-39. PubMed ID: 19553350
    [Abstract] [Full Text] [Related]

  • 18. Akt activation and augmented fibronectin production in hyperhexosemia.
    Xin X, Chen S, Khan ZA, Chakrabarti S.
    Am J Physiol Endocrinol Metab; 2007 Oct 28; 293(4):E1036-44. PubMed ID: 17666488
    [Abstract] [Full Text] [Related]

  • 19. Endothelin-mediated oncofetal fibronectin expression in chronic allograft nephropathy.
    Siddiqui I, Khan ZA, Lian D, Jiang J, Zhong R, Garcia B, Chakrabarti S.
    Transplantation; 2006 Aug 15; 82(3):406-14. PubMed ID: 16906041
    [Abstract] [Full Text] [Related]

  • 20. Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats.
    Jesmin S, Zaedi S, Maeda S, Yamaguchi I, Goto K, Miyauchi T.
    Exp Biol Med (Maywood); 2006 Jun 15; 231(6):925-31. PubMed ID: 16741025
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.